David J. Dykeman, co-managing shareholder of global law firm Greenberg Traurig, LLP’s Boston office and co-chair of the firm’s global Life Sciences & Medical Technology Group, was featured
Continue Reading David Dykeman Featured on Product Success Podcast: Quality and Medical Devices
From floating infrastructure to biohacking, floating solar farms to AgTech, projects that are first of their kind bring with them exciting opportunities, but also unique legal complexities. In this recent
Continue Reading Maneuvering ‘Unicorns’ – Opportunities and Risks of Unprecedented Projects
On April 28, 2020, the United States Patent and Trademark Office (USPTO) announced a new extension of certain submissions and fees under the Coronavirus Aid, Relief, and Economic Security Act
Continue Reading USPTO Announces Extensions Under CARES Act
On March 31, 2020, the United States Patent and Trademark Office (USPTO) announced extension of certain submissions and fees under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act)
Continue Reading USPTO Announces Possible Extensions Under CARES Act
Most of us know that DATA, the beloved android from Star Trek, The Next Generation, is an artificial intelligence (AI) life form from the distant future with a high capacity to problem solve and innovate. But, if DATA were present today and invented a new technology, could he be an inventor on a patent for his invention?
The question of whether AI can legally be an inventor on a patent was recently addressed by the European Patent Office (EPO) and The United Kingdom Intellectual Property Office (UKIPO). The same question is still being evaluated by U.S. Patent and Trademark Office (USPTO) along with solicitation for comments to the patent community.
Continue Reading Could Star Trek’s DATA Be a Patent Inventor?
The patent system in Singapore makes a revolutionary change starting Jan. 1, 2020.
Patent applications filed in Singapore on or before Dec. 31, 2019, can still enjoy the current supplementary
Continue Reading Singapore’s Revised Patent System Starts Jan. 1, 2020
Greenberg Traurig Shareholder Todd Basile authored an article titled “Demystifying Legal Diligence in Tech Deals,” published June 3, 2019, on IPWatchdog.com.
Click here to read the article.
Continue Reading Demystifying Legal Diligence in Tech Deals
David J. Dykeman, co-chair of Greenberg Traurig’s Life Sciences & Medical Technology Group, and Todd Basile, associate at Greenberg Traurig, authored an article that was featured in
Continue Reading Patent Strategy Is Critical for Robotics Innovations
Nearly every patent practitioner has been impacted by the U.S. Supreme Court’s decision in Alice Corp. v. CLS Bank International, 134 S.Ct. 2347 (2014). Alice applied the two-part eligibility
Continue Reading Patent Eligibility After ‘Alice’